Prathikanti Sudha, Rivera Renee, Cochran Ashly, Tungol Jose Gabriel, Fayazmanesh Nima, Weinmann Eva
Department of Psychiatry, School of Medicine, University of California San Francisco, San Francisco, California, United States of America.
Osher Center for Integrative Medicine, University of California San Francisco, San Francisco, California, United States of America.
PLoS One. 2017 Mar 16;12(3):e0173869. doi: 10.1371/journal.pone.0173869. eCollection 2017.
Conventional pharmacotherapies and psychotherapies for major depression are associated with limited adherence to care and relatively low remission rates. Yoga may offer an alternative treatment option, but rigorous studies are few. This randomized controlled trial with blinded outcome assessors examined an 8-week hatha yoga intervention as mono-therapy for mild-to-moderate major depression.
Investigators recruited 38 adults in San Francisco meeting criteria for major depression of mild-to-moderate severity, per structured psychiatric interview and scores of 14-28 on Beck Depression Inventory-II (BDI). At screening, individuals engaged in psychotherapy, antidepressant pharmacotherapy, herbal or nutraceutical mood therapies, or mind-body practices were excluded. Participants were 68% female, with mean age 43.4 years (SD = 14.8, range = 22-72), and mean BDI score 22.4 (SD = 4.5). Twenty participants were randomized to 90-minute hatha yoga practice groups twice weekly for 8 weeks. Eighteen participants were randomized to 90-minute attention control education groups twice weekly for 8 weeks. Certified yoga instructors delivered both interventions at a university clinic. Primary outcome was depression severity, measured by BDI scores every 2 weeks from baseline to 8 weeks. Secondary outcomes were self-efficacy and self-esteem, measured by scores on the General Self-Efficacy Scale (GSES) and Rosenberg Self-Esteem Scale (RSES) at baseline and at 8 weeks.
In intent-to-treat analysis, yoga participants exhibited significantly greater 8-week decline in BDI scores than controls (p-value = 0.034). In sub-analyses of participants completing final 8-week measures, yoga participants were more likely to achieve remission, defined per final BDI score ≤ 9 (p-value = 0.018). Effect size of yoga in reducing BDI scores was large, per Cohen's d = -0.96 [95%CI, -1.81 to -0.12]. Intervention groups did not differ significantly in 8-week change scores for either the GSES or RSES.
In adults with mild-to-moderate major depression, an 8-week hatha yoga intervention resulted in statistically and clinically significant reductions in depression severity.
ClinicalTrials.gov NCT01210651.
重度抑郁症的传统药物治疗和心理治疗存在治疗依从性有限且缓解率相对较低的问题。瑜伽可能提供一种替代治疗选择,但严格的研究较少。这项由结果评估者设盲的随机对照试验,对一项为期8周的哈他瑜伽干预作为轻至中度重度抑郁症的单一疗法进行了研究。
研究人员在旧金山招募了38名符合轻至中度重度抑郁症标准的成年人,依据结构化精神病学访谈以及贝克抑郁量表第二版(BDI)得分在14 - 28分。在筛查时,排除了正在接受心理治疗、抗抑郁药物治疗、草药或营养保健品情绪疗法或身心练习的个体。参与者中68%为女性,平均年龄43.4岁(标准差 = 14.8,范围 = 22 - 72),平均BDI得分为22.4(标准差 = 4.5)。20名参与者被随机分配到每周两次、每次90分钟的哈他瑜伽练习组,为期8周。18名参与者被随机分配到每周两次、每次90分钟的注意力控制教育组,为期8周。由认证的瑜伽教练在大学诊所进行这两种干预。主要结局是抑郁严重程度,从基线到8周每2周通过BDI得分进行测量。次要结局是自我效能感和自尊,在基线和8周时通过一般自我效能量表(GSES)和罗森伯格自尊量表(RSES)得分进行测量。
在意向性分析中,瑜伽组参与者在8周时BDI得分的下降幅度显著大于对照组(p值 = 0.034)。在完成最后8周测量的参与者的亚分析中,瑜伽组参与者更有可能达到缓解,定义为最终BDI得分≤9(p值 = 0.018)。根据科恩d值 = -0.96 [95%置信区间,-1.81至 -0.12],瑜伽在降低BDI得分方面的效应量很大。干预组在GSES或RSES的8周变化得分上没有显著差异。
在患有轻至中度重度抑郁症的成年人中,为期8周的哈他瑜伽干预在统计学和临床上均显著降低了抑郁严重程度。
ClinicalTrials.gov NCT01210651。